You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 146 No. 6, June 1986 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (22)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Implantation of Cultured Thymic Fragments in Patients With Acquired Immunodeficiency Syndrome

Sven A. Danner, MD; Henk-Jan Schuurman, PhD; Joep M. A. Lange, MD; Frits H. J. Gmelig Meyling, PhD; Peter Th. A. Schellekens, MD; Jonne Huber, MD; Louis Kater, MD

Arch Intern Med. 1986;146(6):1133-1136.


Abstract



• Cultured thymic fragments were implanted in one patient with acquired immunodeficiency syndrome (AIDS)-related complex (ARC) and in eight AIDS patients with opportunistic infections (Ols, four patients), Kaposi's sarcoma (KS, two patients), or both (two patients). Thereafter, objective clinical improvement was noted in one patient with 01, and a stable symptom-free condition was observed in the ARC patient and in two other patients with Ols. However, the ARC patient and two of the three patients with Ols developed infections three to six months after implantation. A fourth case of 01 and the patients with KS showed progression of the disease. Peripheral blood investigations for counts of total leukocytes, lymphocytes, and T-lymphocyte subsets as well as for lymphocyte stimulation with mitogens showed no changes interpretable as an improvement of the cellular immune deficiency status. We conclude that cultured thymic fragments have no distinct in vivo effect on the course of AIDS,



Author Affiliations



From the Department of Internal Medicine, Academic Medical Centre, Amsterdam (Drs Danner and Lange); the Division of Immunopathology, the Department of Internal Medicine and Institute for Pathology (Drs Schuurman, Huber, and Kater), and the Department of Clinical Immunology, University Hospital, Utrecht, the Netherlands (Dr Gmelig Meyling); and the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam (Dr Schellekens).


Footnotes



Accepted for publication Oct 17, 1985.

Reprint requests to the Department of Internal Medicine, Academic Medical Centre, Meibergdreef 9,1105 AZ Amsterdam, the Netherlands (Dr Danner).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multifactorial nature of human immunodeficiency virus disease: implications for therapy
Fauci
Science 1993;262:1011-1018.
ABSTRACT  

Letter to the Editor
Hopefl et al.
Nutr Clin Pract 1988;3:5-7.
 

Therapy for Acquired Immunodeficiency Syndrome: Implantation of Cultured Thymic Fragments
Phair
Arch Intern Med 1986;146:1074-1075.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.